| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,809 |
2,602 |
$258K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,457 |
1,346 |
$178K |
| G0378 |
Hospital observation service, per hour |
387 |
350 |
$145K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
429 |
395 |
$23K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
822 |
647 |
$13K |
| 84484 |
|
2,231 |
1,742 |
$5K |
| 80053 |
Comprehensive metabolic panel |
4,566 |
3,853 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
1,383 |
1,283 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
522 |
465 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,880 |
4,240 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
438 |
408 |
$813.01 |
| 84703 |
|
481 |
428 |
$503.71 |
| 87631 |
|
31 |
30 |
$406.70 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,816 |
1,496 |
$374.48 |
| 85610 |
|
1,497 |
1,225 |
$374.27 |
| 83735 |
|
2,590 |
2,124 |
$350.00 |
| 83690 |
|
449 |
413 |
$336.95 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
124 |
119 |
$332.90 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
72 |
68 |
$314.07 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
187 |
156 |
$290.18 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
16 |
15 |
$214.75 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
401 |
318 |
$187.33 |
| 81001 |
|
560 |
520 |
$171.28 |
| 36415 |
Collection of venous blood by venipuncture |
1,113 |
872 |
$151.30 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
479 |
419 |
$146.22 |
| 81003 |
|
890 |
833 |
$109.97 |
| 71045 |
Radiologic examination, chest; single view |
136 |
121 |
$89.69 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
288 |
197 |
$86.21 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
14 |
14 |
$70.93 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
137 |
121 |
$54.77 |
| 83605 |
|
67 |
61 |
$46.62 |
| J2704 |
Injection, propofol, 10 mg |
708 |
503 |
$41.67 |
| 85027 |
|
146 |
129 |
$37.97 |
| 85730 |
|
39 |
39 |
$34.00 |
| 86850 |
|
414 |
341 |
$29.31 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
295 |
219 |
$28.78 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
398 |
338 |
$22.25 |
| 85379 |
|
32 |
30 |
$21.20 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
130 |
123 |
$1.95 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
25 |
24 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
824 |
629 |
$0.00 |
| 86900 |
|
410 |
340 |
$0.00 |
| 87806 |
|
74 |
69 |
$0.00 |
| 80061 |
Lipid panel |
35 |
26 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
975 |
747 |
$0.00 |
| 86901 |
|
407 |
340 |
$0.00 |
| 86592 |
|
114 |
109 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
12 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
55 |
52 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
47 |
38 |
$0.00 |
| 87340 |
|
26 |
25 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49 |
38 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
43 |
38 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
14 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
30 |
28 |
$0.00 |
| 88342 |
|
23 |
12 |
$0.00 |
| 82950 |
|
33 |
32 |
$0.00 |